Loading company…
Omrix Pharmaceuticals develops treatment options for patients with substantial unmet medical needs.
Omrix Pharmaceuticals develops treatment options for patients in areas with substantial unmet medical needs. The company is based in Qiryat Ono, Israel, and is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in